05
Pharmaceutical preparations for use in gene therapy;
biological preparations for use in gene therapy; biological
and pharmaceutical preparations, both comprised of
therapeutic nucleic acids, namely, RNA, for the treatment
and prevention of genetic diseases and disorders, genomic
diseases and disorders, neurological diseases and disorders,
cardiological diseases and disorders, musculoskeletal
diseases and disorders, cancer, infectious diseases, and
immune system related diseases and disorders, metabolic
diseases and disorders, hematological diseases and
disorders, reproductive diseases and disorders,
gynecological diseases and disorders, inflammatory diseases
and disorders, respiratory diseases and disorders,
gastroenterological diseases and disorders, ophthalmological
diseases and disorders, and dermatological diseases and
disorders; pharmaceutical preparations for treating
metabolic diseases and disorders, hematological diseases and
disorders, reproductive diseases and disorders,
gynecological diseases and disorders, inflammatory diseases
and disorders, respiratory diseases and disorders,
gastroenterological diseases and disorders, ophthalmological
diseases and disorders, and dermatological diseases and
disorders, metabolic diseases and disorders, hematological
diseases and disorders, reproductive diseases and disorders,
gynecological diseases and disorders, inflammatory diseases
and disorders, respiratory diseases and disorders,
gastroenterological diseases and disorders, ophthalmological
diseases and disorders, and dermatological diseases and
disorders
42
Testing, inspection, research, and development of
pharmaceutical preparations and biological preparations for
gene therapy; pharmaceutical research and development in the
field of gene therapy; biological research and development
in the field of gene therapy; consulting services in the
fields of biotechnology, pharmaceutical research and
development and genetic science; custom design and
development of biochemical reagents, namely, for use in the
synthesis for others of clinical medical reagents for use in
gene therapy; development of pharmaceutical preparations for
use in gene therapy and gene delivery technology;
development of products being genetic therapies; scientific
research in the field of genetic engineering, biotechnology
research services, and research and development of new
products in the field of gene therapeutics and research
tools; research and development in the biotechnology field;
scientific and medical research and development in the
fields of genetic diseases and disorders, genomic diseases
and disorders, neurological diseases and disorders,
cardiological diseases and disorders, musculoskeletal
diseases and disorders, cancer, infectious diseases, and
immune system related diseases and disorders, metabolic
diseases and disorders, hematological diseases and
disorders, reproductive diseases and disorders,
gynecological diseases and disorders, inflammatory diseases
and disorders, respiratory diseases and disorders,
gastroenterological diseases and disorders, ophthalmological
diseases and disorders, and dermatological diseases and
disorders of autoimmune, cancer, cardiovascular, central
nervous system, diabetic, dermatological, endocrine, fungal,
gastrointestinal, hematologic, hepatological, immunological,
infectious, inflammatory, liver, menopausal, metabolic,
musculoskeletal, neurological, ophthalmologic, orthopedic,
pain, peripheral nervous system, psychiatric, respiratory,
renal, urogenital, urological, and viral diseases and
disorders and complications associated therewith; scientific
research and product development services for others in the
pharmaceutical, biotechnology, medical and agriculture
fields; testing, inspection, research, or development of
pharmaceutical preparations for gene therapy and gene
delivery technology; biomedical research and development,
scientific research and development, pharmaceutical research
and development and product development services in the
fields of genome editing, gene editing, genome engineering,
gene modulation, genetic diseases, gene therapy, and cell
therapy; product development in the fields of genetic
therapies, gene delivery technologies, and effectors to
regulate, modulate, and characterize disease states;
conducting clinical trials for others in the field of gene
therapy design and delivery; biomedical research in the
field of gene therapy design and delivery; gene therapy
design and product delivery development of biochemical
assays; biomedical research and development, scientific
research and development, pharmaceutical research and
development and product development in the fields of genetic
diseases and disorders, genomic diseases and disorders,
neurological diseases and disorders, cardiological diseases
and disorders, musculoskeletal diseases and disorders,
cancer, infectious diseases, and immune system related
diseases and disorders, metabolic diseases and disorders,
hematological diseases and disorders, reproductive diseases
and disorders, gynecological diseases and disorders,
inflammatory diseases and disorders, respiratory diseases
and disorders, gastroenterological diseases and disorders,
ophthalmological diseases and disorders, and dermatological
diseases and disorders, autoimmune, cancer, cardiovascular,
central nervous system, diabetic, dermatological, endocrine,
fungal, gastrointestinal, hematologic, hepatological,
immunological, infectious, inflammatory, liver, menopausal,
metabolic, musculoskeletal, neurological, ophthalmologic,
orthopedic, pain, peripheral nervous system, psychiatric,
respiratory, renal, urogenital, urological, and viral
diseases and disorders; medical research services, namely,
scientific research in the fields of genetic engineering and
gene therapy services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen